Agrupación Estratégica en Gestión y Producción sostenible de Biorrecursos (BioReDes)
Agrupación estratégica de I+D+i
![Foto de Emilio](/img/nophoto.png)
Emilio
Pérez Trallero
Publicaciones en las que colabora con Emilio Pérez Trallero (22)
2019
-
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
-
HTLV testing of solid organ transplant donors
Clinical Transplantation
-
HTLV-1 infection in solid organ transplant donors and recipients in Spain
BMC Infectious Diseases, Vol. 19, Núm. 1
2017
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
2014
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
2010
-
Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229
-
Infection by the type 2 human immunodeficiency virus and types 1 and 2 human lymphotropic virus in Spain
Medicina Clinica
2005
-
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972
-
Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain
Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70
2004
-
HIV-2 and HTLV-I/II infections in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182
2002
-
Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain
Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667
-
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]
Journal of Antimicrobial Chemotherapy
-
Infection with retroviruses other than HIV-1 in Spain: A retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II
HIV Clinical Trials, Vol. 3, Núm. 5, pp. 397-402
2001
-
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999
Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 11, pp. 3226-3228
2000
-
Prevalence of HTLV infection in pregnant women in Spain
Sexually Transmitted Infections, Vol. 76, Núm. 5, pp. 366-370
1996
-
Epidemiology of HIV-2 infection in Spain
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 5, pp. 383-388